CBIO
Crescent Biopharma, Inc.
14.60$
-1.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81.44 | 105.58 | 0.09 | – | – | – | 22.23 | 2.25 | 0.14 | 0.02 | – | 1.04 | |
| – | – | – | 0.90 | 0.67 | 2.08 | 2.08 | – | 1.96 | 0.24 | 0.05 | 0.01 | |
| 81.44 | 105.58 | 0.09 | -0.90 | -0.67 | -2.08 | 22.23 | 2.25 | 0.14 | 0.02 | -0.05 | 1.04 | |
| 106.06 | 131.77 | 109.53 | 81.99 | 97.68 | 108.73 | 98.27 | 92.30 | 54.05 | 31.69 | 36.56 | 13.26 | |
| 35.75 | 41.06 | 40.69 | 33.45 | 27.81 | 33.20 | 36.62 | 33.26 | 36.33 | 30.33 | 21.27 | 2.44 | |
| 141.81 | 172.83 | 150.22 | 114.54 | 125.49 | 141.92 | 134.89 | 125.56 | 90.38 | 62.02 | 65.01 | 15.70 | |
| -60.37 | -67.25 | -150.14 | -115.43 | -125.49 | -141.92 | -112.66 | -123.31 | -90.24 | -62.00 | -65.01 | -14.66 | |
| – | – | – | – | – | – | – | – | – | – | 1.11 | 0.21 | |
| -60.27 | -67.17 | -149.65 | -113.22 | -117.61 | -133.84 | -111.60 | -123.27 | -88.88 | -58.25 | -63.22 | -14.59 | |
| – | – | – | – | 7.87 | -8.73 | – | – | – | – | – | 0.19 | |
| -60.27 | -67.17 | -149.65 | -113.22 | -117.61 | -125.11 | -111.60 | -123.27 | -88.88 | -58.25 | -63.22 | -14.78 | |
| -59.51 | -66.24 | -149.24 | -114.54 | -124.81 | -131.76 | -112.07 | -122.80 | -89.84 | -61.76 | -57.55 | -14.37 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.